Giovanni Fiorillo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.
Journal: Italian journal of dermatology and venereology
Published: August 24, 2026
Adherence to the Mediterranean diet is inversely associated with hematologic inflammatory indices in adults seeking a weight loss dietary program: a cross-sectional study.
Journal: European journal of nutrition
Published: March 27, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
Journal: Dermatology and therapy
Published: February 04, 2026
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 28, 2025
Risankizumab differentially modulates circulating T-cell populations in psoriasis according to autoreactivity status.
Journal: Journal of dermatological science
Published: March 26, 2025
Gluten-free breadsticks with Ganoderma-fermented corncobs: technological and nutritional features.
Journal: Journal of the science of food and agriculture
Published: November 15, 2024
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study.
Journal: Journal of drugs in dermatology : JDD
Published: August 02, 2024
First Joint Oscillation Analysis of Super-Kamiokande Atmospheric and T2K Accelerator Neutrino Data.
Journal: Physical review letters
Published: May 22, 2024
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review.
Journal: Clinical, cosmetic and investigational dermatology
Published: January 10, 2024
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients.
Journal: Journal of autoimmunity
Published: January 09, 2024
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study.
Journal: Journal of personalized medicine
Published: December 17, 2023
Last Updated: 09/26/2026